LH

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript

LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects

LH or MEDP: Which Is the Better Value Stock Right Now?

Labcorp to Present at the Jefferies Global Healthcare Conference